SynthesisAIDS care2008
Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care.
Synthesis in AIDS care, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The benefits of yoga for people living with HIV/AIDS: A systematic review and meta-analysis.Complementary therapies in clinical practice · 2019Pooled it
- Trial
- Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers.Antimicrobial agents and chemotherapy · 2012Trial
- Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients.Antimicrobial agents and chemotherapy · 2012Trial
- Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.Antimicrobial agents and chemotherapy · 2012Trial
- Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients.Antimicrobial agents and chemotherapy · 2011Trial
- Acu/Moxa for distal sensory peripheral neuropathy in HIV: a randomized control pilot study.The Journal of the Association of Nurses in AIDS Care : JANACTrial
- Effects of acute THC challenge on behavior and neuroinflammation in HIV-1 Tg26 mice vary based on HIV status, chronic THC history, and sex.Brain, behavior, and immunity · 2026Article
- Modeling NRTIs and PIs class drug therapy on the dynamics of HIV infection with real patient data analysis and optimized control strategy.Scientific reports · 2026Article
- Poor Quality of Life in HIV-Infected Men Who Have Sex with Men is Associated with Excess-Type Constitution of Traditional Chinese Medicine.Evidence-based complementary and alternative medicine : eCAM · 2023Article
- Cannabis and complementary/alternative self-treatment approaches for symptom management among African American persons living with HIV.AIDS care · 2023Article
- Complementary and alternative medicine use among people living with HIV in Shiraz, Southern Iran.Frontiers in public health · 2023Article
- Article
- Prevalence, Perception and Predictors of Concomitant Herbal Medicine Use among HIV/AIDS and Tuberculosis Patients in Metekel Zone, Northwest Ethiopia: A Cross-Sectional Study.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Attitude and practice toward traditional medicine among hypertensive patients on follow-up at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia.SAGE open medicine · 2022Article
- Complementary and alternative medicine use and its associated factors among hypertensive patients in Debre Tabor General Hospital, Ethiopia.Metabolism open · 2021Article
- Prevalence and correlates of complementary and alternative medicine use among diabetic patients in a resource-limited setting.Metabolism open · 2021Article
- Demand curve analysis of marijuana use among persons living with HIV.Drug and alcohol dependence · 2021Article
- A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong.PloS one · 2021Article
- Evolution of Drug Interactions With Antiretroviral Medication in People With HIV.Open forum infectious diseases · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Use of complementary and alternative medicine (CAM) is prevalent among HIV-positive individuals despite the success of antiretroviral treatments and limited evidence of CAM's safety and efficacy. To characterize the potential impact of CAM use on HIV care, we conducted a systematic review of 40 studies of CAM use among HIV-positive people. The goals of this review are to: (1) describe the demographic, biomedical, psychosocial and health behavior correlates of CAM use; (2) characterize patient-reported reasons for CAM use; and (3) identify methodological and conceptual limitations of the reviewed studies. Findings confirm that a high proportion of HIV-positive individuals report CAM use (M=60%). Overall, CAM use is more common among HIV-positive individuals who are men who have sex with men (MSM), non-minority, better educated and less impoverished. The use of CAM is also associated with greater HIV-symptom severity and longer disease duration. HIV-positive CAM users commonly report that they use CAM to prevent or alleviate HIV-related symptoms, reduce treatment side-effects and improve quality of life. Findings regarding the association between CAM use, psychosocial adjustment and adherence to conventional HIV medications are mixed. While the reviewed studies are instrumental in describing the characteristics of HIV-positive CAM users, this literature lacks a conceptual framework to identify causal factors involved in the decision to use CAM or explain implications of CAM use for conventional HIV care. To address this concern, we propose the use of health behavior theory and discuss implications of review findings for HIV care providers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.